A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : NTG

Search Conditions:
Search Keyword : NTG
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: NTG
Appearance Frequency: 2356 time(s)
Long forms: 76

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
nitroglycerin
(997 times)
Cardiology
(391 times)
NO (147 times)
SNP (57 times)
ACh (55 times)
1975 Hemodynamic effects of nitroglycerin in acute myocardial infarction.
normal-tension glaucoma
(902 times)
Ophthalmology
(691 times)
IOP (326 times)
POAG (313 times)
MD (100 times)
0 ["Ganglion Cells Complex" and Retinal Nerve Fiber Layer in Hypertensive and Normal-Tension Glauc].
nontransgenic
(190 times)
Cardiology
(47 times)
Tg (84 times)
AD (23 times)
cTnI (9 times)
1994 Expression of c-fos mRNA after a mild focal cerebral ischemia in SOD-1 transgenic mice.
N-methyl-N'-nitro-N-nitrosoguanidine
(73 times)
Microbiology
(28 times)
EMS (6 times)
UV (4 times)
HA (3 times)
1969 N-METHYL-N'-NITRO-N-NITROSOGUANIDINE AS A MUTAGEN FOR BLUE-GREEN ALGAE: EVIDENCE FOR REPAIR(1).
normotriglyceridemic
(25 times)
Vascular Diseases
(6 times)
HTG (22 times)
TG (12 times)
Apo (6 times)
1979 Changes in plasma very low density and low density lipoprotein content, composition, and size after a fatty meal in normo- and hypertriglyceridemic man.
nontoxic goiter
(17 times)
Endocrinology
(9 times)
GD (5 times)
HT (5 times)
AITD (2 times)
1989 Tumour necrosis factor synergises with gamma interferon on the induction of mRNA for DR alpha chain on thyrocytes from Graves' disease and non toxic goitre.
nitrosoguanidine
(15 times)
Microbiology
(9 times)
UV (4 times)
EMS (3 times)
AD (1 time)
1974 Lack of chemically induced mutation in repair-deficient mutants of yeast.
nodular goiter
(10 times)
Endocrinology
(8 times)
GD (7 times)
AITD (4 times)
HE (3 times)
1993 Reduced activation of suppressor T lymphocytes by specific antigens in autoimmune thyroid disease.
non-TG
(10 times)
Cardiology
(6 times)
Tg (10 times)
Ca-L (2 times)
LV (2 times)
1999 SERCA1a can functionally substitute for SERCA2a in the heart.
10  non-transgenic littermates
(8 times)
Cardiology
(4 times)
TG (3 times)
cTnI (2 times)
AC8 (1 time)
1999 Overexpression of hexokinase II increases insulinand exercise-stimulated muscle glucose uptake in vivo.
11  nartograstim
(6 times)
Physiology
(2 times)
G-CSF (3 times)
PEG (2 times)
AUC (1 time)
1995 Saturable uptake of a recombinant human granulocyte colony-stimulating factor derivative, nartograstim, by the bone marrow and spleen of rats in vivo.
12  nephrotoxic globulin
(6 times)
Nephrology
(3 times)
GBM (2 times)
BSA (1 time)
CVF (1 time)
1979 The interaction of anti-glomerular basement membrane antibody deposition with immune elimination of bovine serum albumin in the rabbit.
13  nateglinide
(5 times)
Pharmacology
(2 times)
ACN (1 time)
CDI (1 time)
CH (1 time)
2007 Nateglinide quantification in rabbit plasma by HPLC: optimization and application to pharmacokinetic study.
14  nontransgenic mice
(5 times)
Cardiology
(1 time)
CA-MEK1 (1 time)
CRPtg (1 time)
FS (1 time)
2008 Exaggerated neointima formation in human C-reactive protein transgenic mice is IgG Fc receptor type I (Fc gamma RI)-dependent.
15  nitrogranulogen
(4 times)
Allergy and Immunology
(2 times)
IP (2 times)
4HCy (1 time)
AA (1 time)
1989 Nitrogranulogen: a strong inhibitor of human lymphocyte proliferation.
16  nodular thyroid goiter
(4 times)
Neoplasms
(3 times)
PTC (4 times)
EGFR (1 time)
ER (1 time)
2012 Differential expression patterns of estrogen receptor (ER)-beta splice variants between papillary thyroid cancer and nodular thyroid goiter.
17  non-treatment group
(4 times)
Pathology
(1 time)
CG (2 times)
ASDH (1 time)
CMG (1 time)
2008 [Effect of conservative treatment in the management of low-degree urogenital prolapse].
18  nontoxic multinodular goiter
(3 times)
Endocrinology
(2 times)
GD (3 times)
HT (2 times)
RT-PCR (2 times)
1996 Expression of tumour necrosis factor-alpha (TNF-alpha) mRNA and protein in pathological thyroid tissue and carcinoma cell lines.
19  nontransgenic control
(3 times)
Physiology
(3 times)
AC (1 time)
AC8 (1 time)
ANF (1 time)
1997 Transgenic manipulation of beta-adrenergic receptor kinase modifies cardiac myocyte contraction to norepinephrine.
20  normal tension glaucoma patients
(3 times)
Ophthalmology
(3 times)
AGD (1 time)
BP (1 time)
CDI (1 time)
2002 [The relationship between retrobulbar blood flow velocity and glaucoma damage. An intraindividual comparison].
21  nortrachelogenin
(3 times)
Biochemistry
(2 times)
BC (1 time)
DMBA (1 time)
ENL (1 time)
2005 Structural determinants of plant lignans for growth of mammary tumors and hormonal responses in vivo.
22  NTG group
(3 times)
Gastrointestinal Diseases
(1 time)
SSOH (2 times)
CNR (1 time)
CTA (1 time)
2013 Differentiation by imaging of superior segmental optic hypoplasia and normal-tension glaucoma with inferior visual field defects only.
23  natural temperature gradient
(2 times)
Botany
(2 times)
CHD (2 times)
ATG (1 time)
TDP (1 time)
2012 Novel, cyclic heat dissipation method for the correction of natural temperature gradients in sap flow measurements. Part 1. Theory and application.
24  negative toxicology group
(2 times)
Substance-Related Disorders
(1 time)
ISS (2 times)
PTG (2 times)
AIS (1 time)
2010 Motor vehicle collision fatalities involving alcohol and illicit drugs in Greece: the need for management protocols and a reassessment of surveillance.
25  nitroglycerin-mediated vasodilation
(2 times)
Cardiology
(1 time)
FMD (2 times)
BMI (1 time)
PP (1 time)
2007 The association between right coronary artery morphology and endothelial function.
26  nitroglycerol
(2 times)
Neurology
(1 time)
PACAP (2 times)
CS (1 time)
CSF (1 time)
2012 Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice.
27  non-training group
(2 times)
Medicine
(1 time)
CAD (1 time)
CFI (1 time)
DBP (1 time)
2014 Physical ischaemia induced by isometric exercise facilitated collateral development in the remote ischaemic myocardium of humans.
28  normal-tension primary open-angle glaucoma
(2 times)
Ophthalmology
(2 times)
avD (1 time)
IOP (1 time)
POAG (1 time)
2006 Intravascular oxygen saturation in retinal vessels in normal subjects and open-angle glaucoma subjects.
29  exercise-nitroglycerin
(1 time)
Nuclear Medicine
(1 time)
CAD (1 time)
MIBI (1 time)
SPECT (1 time)
1994 [Exercise-nitroglycerine technetium-99m-2-methoxy isobutyl isonitrile tomoscintigraphic imaging for identifying diseased coronary vessels: comparison with thallium-201 standard exercise-redistribution study].
30  intracoronary-nitroglycerin
(1 time)
Cardiology
(1 time)
EU (1 time)
1997 Pyrogenic reactions in patients undergoing cardiac catheterization associated with contaminated glass medicine cups.
31  N'-nitro-N-nitrosoguanidine
(1 time)
Biomedical Engineering
(1 time)
SSF (1 time)
1989 The use of cellulases from a beta-glucosidase-hyperproducing mutant of Trichoderma reesei in simultaneous saccharification and fermentation of wheat straw.
32  N(G)-monomethyl-L-arginine, acetylcholine, nitroglycerin
(1 time)
Biomedical Engineering
(1 time)
NO (1 time)
2002 Evaluation of basic performance and applicability of a newly developed in vivo nitric oxide sensor.
33  nateglinide tablets
(1 time)
Drug Discovery
(1 time)
CCS (1 time)
2010 Formulation, development, and optimization of immediate release nateglinide tablets by factorial design.
34  National Task Group
(1 time)
Neurology
(1 time)
DS (1 time)
DSQIID (1 time)
2017 A Multicentre Italian Validation Study in Aging Adults with Down Syndrome and Other Forms of Intellectual Disabilities: Dementia Screening Questionnaire for Individuals with Intellectual Disabilities.
35  national tuberculosis guidelines
(1 time)
Primary Health Care
(1 time)
--- 2014 An audit of diagnosis and treatment of tuberculosis in Ethiopia.
36  neutrophils with cytoplasmic toxic granules
(1 time)
Pathology
(1 time)
--- 1990 [Correlation between intracellular alkaline phosphatase activities and incidence of toxic granules in neutrophilia].
37  new tissue growth
(1 time)
Dentistry
(1 time)
CEJ (1 time)
CG (1 time)
EG (1 time)
2003 Guided tissue regeneration in smokers: effect of aggressive anti-infective therapy in Class II furcation defects.
38  nicotine plus TENS group
(1 time)
General Surgery
(1 time)
EPM (1 time)
NG (1 time)
TENS (1 time)
2006 Transcutaneous electrical nerve stimulation in viability of a random skin flap in nicotine-treated rats.
39  nighttime GERD
(1 time)
Gastroenterology
(1 time)
GERD (1 time)
GERD-SMQ (1 time)
2010 The relationship between the prevalence of nighttime gastroesophageal reflux disease and disease severity.
40  nitrate tolerance, using nitroglycerine
(1 time)
Cardiology
(1 time)
2MN (1 time)
5MN (1 time)
cGMP (1 time)
2010 Differences between nitrates: role of isosorbide 2-mononitrate.
41  nitroesters e.g. glyceryltrinitrate
(1 time)
Pharmacology
(1 time)
--- 1986 Biological effects of organic nitroesters and their mechanism of action.
42  nitroglycerin 25 microg x kg(-1)
(1 time)
Sports Medicine
(1 time)
ACH (1 time)
1998 Exercise reduces epicardial coronary artery wall stiffness: roles of cGMP and cAMP.
43  nitroglycerin induced
(1 time)
History of Medicine
(1 time)
--- 2003 [Endothelium-dependent and independent vasodilation in young males with previous myocardial infarction].
44  nitroglycerin ointment
(1 time)
Cardiology
(1 time)
CHF (1 time)
1981 Effects of nitroglycerin ointment on plasma norepinephrine and cyclic nucleotides in congestive heart failure.
45  nitroglycerin patches
(1 time)
Cardiology
(1 time)
--- 1989 Intermittent transdermal nitroglycerin monotherapy in stable exercise-induced angina: a comparison with a continuous schedule.
46  nitroglycerin tablets
(1 time)
Drug Therapy
(1 time)
--- 1975 Efficacy of beta adrenergic blockade in coronary heart disease: propranolol in angina pectoris.
47  nitroglycerin therapy
(1 time)
Cardiology
(1 time)
AMI (1 time)
ATAMI (1 time)
LV (1 time)
1989 Improved left ventricular function and topography by prolonged nitroglycerin therapy after acute myocardial infarction.
48  nitroglycerin-induced dilatation
(1 time)
Cardiology
(1 time)
CHF (1 time)
FMD (1 time)
IMT (1 time)
2004 Reduced vascular compliance is associated with impaired endothelium-dependent dilatation in the brachial artery of patients with congestive heart failure.
49  nitroglycerin-mediated dilation
(1 time)
Cardiology
(1 time)
CAD (1 time)
FMD (1 time)
2011 Impact of acute caffeine ingestion on endothelial function in subjects with and without coronary artery disease.
50  nitroglycerine application
(1 time)
Medicine
(1 time)
TT (1 time)
2003 [Usefulness of the tilt test with nitroglycerine application in diagnosing of patients with unexplained syncope: new aspects of the well-known problem].
51  nitroglycerine, i.e. endothelium-independent dilation
(1 time)
Medicine
(1 time)
EDD (1 time)
FMD (1 time)
IFG (1 time)
2013 Regular aerobic exercise protects against impaired fasting plasma glucose-associated vascular endothelial dysfunction with aging.
52  nitroglycerine-mediated dilation
(1 time)
Energy Metabolism
(1 time)
FMD (1 time)
REC (1 time)
2007 Heart rate recovery does not predict endothelial function in obese women.
53  no-tube group
(1 time)
Gastroenterology
(1 time)
ITG (1 time)
TG (1 time)
2011 Nasogastric decompression for radical gastrectomy for gastric cancer: a prospective randomized controlled study.
54  no-tubing gait
(1 time)
Neurology
(1 time)
ANOVA (1 time)
ARTG (1 time)
ATG (1 time)
2014 Effects of novel tubing gait on neuromuscular imbalance in cerebral palsy.
55  nodular toxic goitre
(1 time)
Diagnostic Imaging
(1 time)
--- 2017 Study of factors that influence the outcome of 131I treatment in hyperthyroidism secondary to nodular goitre.
56  non-target
(1 time)
Cardiology
(1 time)
AUC (1 time)
CABG (1 time)
CI (1 time)
2007 Cognitive brain function after hypothermic circulatory arrest assessed by cognitive P300 evoked potentials.
57  non-tattooed group
(1 time)
Medicine
(1 time)
ICG (1 time)
LAR (1 time)
TG (1 time)
2018 Usefulness of colonic tattooing using indocyanine green in patients with colorectal tumors.
58  non-TG mice
(1 time)
Cardiology
(1 time)
alpha1A-AR (1 time)
FS (1 time)
LV (1 time)
2006 Transgenic alpha1A-adrenergic activation limits post-infarct ventricular remodeling and dysfunction and improves survival.
59  Non-transgenic siblings
(1 time)
Cardiology
(1 time)
Fc (1 time)
Myc (1 time)
TAM (1 time)
2013 C-Myc induced compensated cardiac hypertrophy increases free fatty acid utilization for the citric acid cycle.
60  non-transgenic wild type
(1 time)
Medicine
(1 time)
CRYAB (1 time)
HSP (1 time)
2010 Protein quality control in protection against systolic overload cardiomyopathy: the long term role of small heat shock proteins.
61  Non-traumatic group
(1 time)
Medicine
(1 time)
ED (1 time)
ITF (1 time)
OSF (1 time)
2000 Malignant potential of oral submucous fibrosis due to intraoral trauma.
62  nontargeted
(1 time)
Nanotechnology
(1 time)
TG CS nanoparticles (1 time)
2016 Biodistribution and pharmacokinetics of Mad2 siRNA-loaded EGFR-targeted chitosan nanoparticles in cisplatin sensitive and resistant lung cancer models.
63  nontransgenic littermate control mice
(1 time)
Cardiology
(1 time)
CREB (1 time)
2007 The CREB leucine zipper regulates CREB phosphorylation, cardiomyopathy, and lethality in a transgenic model of heart failure.
64  normal fasting plasma triglycerides
(1 time)
Endocrinology
(1 time)
FTG (1 time)
GES (1 time)
2015 Treatment of Patients with Obese Type 2 Diabetes with Tantalus-DIAMOND Gastric Electrical Stimulation: Normal Triglycerides Predict Durable Effects for at Least 3 Years.
65  normal TG
(1 time)
Biology
(1 time)
ApoCIII (1 time)
HTG (1 time)
TG (1 time)
2008 Apolipoprotein CIII polymorphism and triglyceride levels of a Japanese population living in Southern Brazil.
66  normal transgene
(1 time)
Biochemistry
(1 time)
AST (1 time)
GGT (1 time)
I/R (1 time)
2018 TNIP1 alleviates hepatic ischemia/reperfusion injury via the TLR2-Myd88 pathway.
67  normal treated group
(1 time)
Biology
(1 time)
ADRs (1 time)
MCG (1 time)
NCG (1 time)
2016 Pharmacokinetic-Pharmacodynamic Modeling to Study the Antipyretic Effect of Qingkailing Injection on Pyrexia Model Rats.
68  normal triglyceridaemia subgroup
(1 time)
Genetics
(1 time)
apo (1 time)
APOC3 (1 time)
CHD (1 time)
2005 Association of Sst I polymorphism in apolipoprotein C3 gene with hypertriglyceridaemia in coronary atherosclerotic heart disease and type II diabetes mellitus in Chinese population.
69  normal triglyceride
(1 time)
Molecular Biology
(1 time)
BMI (1 time)
CaSR (1 time)
2014 The calcium-sensing receptor R990G polymorphism is associated with increased risk of hypertriglyceridemia in obese Chinese.
70  normal triglyceride group
(1 time)
Transplantation
(1 time)
HCG (1 time)
HTG (1 time)
NCG (1 time)
2001 Hyperlipidemia as a risk factor of renal allograft function impairment.
71  normal-temperature group
(1 time)
Veterinary Medicine
(1 time)
AR (1 time)
COP (1 time)
GF (1 time)
2011 Active components of common traditional Chinese medicine decoctions have antioxidant functions.
72  normal-TSH group
(1 time)
General Surgery
(1 time)
DTC (1 time)
LTG (1 time)
TSH (1 time)
2015 The Effect of Thyroid-Stimulating Hormone on Tumor Size in Differentiated Thyroid Carcinoma.
73  normotriglyceridaemic patients
(1 time)
Vascular Diseases
(1 time)
CETP (1 time)
HTG (1 time)
LDL (1 time)
1995 Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistance.
74  Nose-to-ground
(1 time)
Anesthesiology
(1 time)
DD (1 time)
TT (1 time)
2009 Effect of detomidine on visceral and somatic nociception and duodenal motility in conscious adult horses.
75  post-nitroglycerin
(1 time)
Pathology
(1 time)
EID (1 time)
2011 Endothelium-independent dilation in children and adolescents.
76  sequence, TGGCAGSCTCGGCST(G)YTCTCTCT
(1 time)
Biochemistry
(1 time)
--- 1988 Conserved region of the rat alpha-lactalbumin promoter is a target site for protein binding in vitro.